Company intelligence / Profile preview
Taisho Pharmaceutical
- Ownership
- Private
- Employees
- ~9000
- Development stage
- Commercial
Overview
Taisho has multiple commercialized products in both OTC and prescription markets. Its most successful prescription product to date has been clarithromycin (“Clarith”), launched in Japan in the early ‘90s. Other notable launches include luseogliflozin for type 2 diabetes and iguratimod for rheumatoid arthritis. The company’s OTC brands such as Lipovitan-D energy drink and RiUP hair growth agent dominate their respective Japanese market segments.
- Therapeutic areas
- CardiovascularRheumatologyImmunologyEndocrinologyDermatology
- Modalities
- Small moleculeSynthetic peptideProbioticsNanobody therapyBispecific monoclonal antibody
- Industry
- Biotech
Drug pipeline
36 assets35 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Taisho Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Taisho Pharmaceutical.